UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Ono Pharma, BMS unveil two P3 trial analyses for Opdivo
Ono Pharmaceutical and Bristol-Myers Squibb have presented pooled data on t...
by Lee Han-soo
|
2019-09-18 15:48
라인
Macrogen, Psomagen win patent for blockchain technology in US
Macrogen and Psomagen said that they have registered a patent for its block...
by Lee Han-soo
|
2019-09-18 14:36
라인
Regulator delays decision on delisting Kolon TissueGene
The Korea Exchange said it has delayed its decision whether to delist Kolon...
by Jeong Sae-im
|
2019-09-18 14:27
라인
Korea narrows pharmaceutical trade gap in 5 years
Korea's deficit in pharmaceuticals trade has been on the decline for th...
by Lee Han-soo
|
2019-09-18 11:38
라인
CJ Healthcare to export gastroesophageal reflux treatment to Indonesia
CJ Healthcare said that it plans to export K-CAB (Ingredient: tegoprazan), ...
by Lee Han-soo
|
2019-09-18 11:37
라인
Will Tagrisso study results affect use of EGFR TKIs in lung cancer?
AstraZeneca’s imminent announcement of overall survival (OS) data of Tagris...
by Kim Yun-mi
|
2019-09-18 11:36
라인
Hanmi spurs new immunotherapy development through open innovation
Hanmi Pharmaceutical said it is launching new development projects in the f...
by Lee Han-soo
|
2019-09-17 18:14
라인
Government allows new drugs to treat multidrug-resistant TB
The health authorities said they would amend tuberculosis (TB) treatment gu...
by Kim Eun-young
|
2019-09-17 16:28
라인
Regulator finds no trace of carcinogen in GSK’s heartburn drug
The Ministry of Food and Drug Safety said that it has failed to find the tr...
by Lee Han-soo
|
2019-09-17 16:27
라인
‘Lundbeck to work with parliament to prevent suicide in Korea’
Lundbeck, which sells anti-depressants Lexapro and Brintellix, dementia tre...
by Kim Yun-mi
|
2019-09-17 15:19
라인
Shinpoong's malaria treatment expands global presence
Shinpoong Pharmaceutical said that Pyramax, its malaria treatment, is quick...
by Lee Han-soo
|
2019-09-17 15:13
라인
Noom, NCC to jointly research total healthcare for cancer patients
Noom Korea said that that it would conduct joint research with the National...
by Lee Han-soo
|
2019-09-17 11:28
라인
SK Bioscience to export influenza vaccine to Asian countries
SK Bioscience will export 250,000 doses of Skycellflu, the first cell-cultu...
by Lee Han-soo
|
2019-09-17 11:27
라인
Biotech startups seek IPO via ‘growth potential exception’ policy
An increasing number of biotech companies are eyeing on the Korea Exchange’...
by Jeong Sae-im
|
2019-09-17 11:26
라인
Gyeongsang National University develops early dementia detection kit
Researchers at Gyeongsang National University have developed a kit that can...
by Lee Han-soo
|
2019-09-16 18:05
라인
Myongji Hospital to hold international liver symposium
Myongji Hospital said that it plans to hold its fourth annual "Myongji Inte...
by Lee Han-soo
|
2019-09-16 17:42
라인
Lenvima to get benefit as 1st-line treatment of hepatocellular carcinoma
Lenvima (ingredient: lenvatinib), a new liver cancer drug that arrived in a...
by Kim Yun-mi
|
2019-09-16 16:20
라인
'Roche Korea to put patient accessibility first'
Roche Korea, the number one company in the domestic anticancer market, is l...
by Lee Han-soo
|
2019-09-16 15:41
라인
Regulator inspects heartburn drugs after US finds carcinogen
After U.S. health officials said they detected low levels of a potentially ...
by Lee Hye-seon
|
2019-09-16 14:01
라인
GC’s Hunter syndrome drug to get priority screening in China
GC said that China’s National Medical Products Administration (NMPA) has de...
by Lee Han-soo
|
2019-09-16 13:56
-
이전
91
92
93
94
95
96
97
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top